Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Translational Discovery is Scopus-indexed (Q2, CiteScore 2.8), WoS ESCI, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2768-0622Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 214 / 669 | 68th | Q2 |
| Clinical Biochemistry | 86 / 124 | 31st | Q3 |
| Genetics | 256 / 357 | 28th | Q3 |
| Molecular Medicine | 146 / 179 | 18th | Q4 |
| Cell Biology | 242 / 289 | 16th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 2.8.
Clinical and Translational Discovery is Q2 in Medicine (all) (rank 214 of 669), Q3 in Clinical Biochemistry (rank 86 of 124) and Q3 in Genetics (rank 256 of 357), by CiteScore 2025. It is ranked in 5 subject areas in all.
Clinical and Translational Discovery is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.8, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.485, quartile Q3, with an H-index of 14.
The publisher lists an article processing charge of about US$2,420 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical and Translational Discovery is published by John Wiley and Sons Inc. Its ISSN is 2768-0622.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Clinical and Translational Discovery has an h-index of 17 and a 2-year mean of 1.52 citations per paper (OpenAlex). Its Scopus CiteScore is 2.8, quartile Q2. On 2-year citations it ranks #187 of 646 Scopus journals in Medicine (all).
Clinical and Translational Discovery published 86 papers in 2025; its busiest recent year was 2022 with 142. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (54.2%), United States (8.4%) and Iran (4.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.